|
2025-04-23 |
2025-04-22 |
VP
Vente planifiée
|
Hui Yvonne
Principal Accounting Officer
Dirigeant
|
1 000
-5.6%
23,70
31 521 USD
|
1 000
-5.6%
|
23,70
|
100 000 USD
|
|
|
2025-04-23 |
2025-04-21 |
V
Vente
|
Linetsky David
SVP, Life Sciences
Dirigeant
|
1 000
-2.9%
23,04
5 991 USD
|
1 000
-2.9%
|
23,04
|
100 000 USD
|
|
|
2025-04-23 |
2025-04-21 |
V
Vente
|
Hui Yvonne
Principal Accounting Officer
Dirigeant
|
1 000
-4.0%
23,04
22 881 USD
|
1 000
-4.0%
|
23,04
|
100 000 USD
|
|
|
2025-04-17 |
2025-04-16 |
V
Vente
|
VanDuyn Amy Beth
SVP, Human Resources
Dirigeant
|
624
-0.5%
23,81
14 856 USD
|
624
-0.5%
|
23,81
|
14 856 USD
|
|
|
2025-04-17 |
2025-04-16 |
VP
Vente planifiée
|
Hui Yvonne
Principal Accounting Officer
Dirigeant
|
418
-1.7%
23,66
9 890 USD
|
418
-1.7%
|
23,66
|
9 890 USD
|
|
|
2025-04-17 |
2025-04-16 |
V
Vente
|
Indig Chaim
Chief Executive Officer
Administrateur exécutif
|
3 091
-0.2%
23,81
73 588 USD
|
3 091
-0.2%
|
23,81
|
73 588 USD
|
|
|
2025-04-17 |
2025-04-16 |
VP
Vente planifiée
|
Linetsky David
SVP, Life Sciences
Dirigeant
|
2 488
-1.1%
23,66
58 866 USD
|
2 488
-1.1%
|
23,66
|
58 866 USD
|
|
|
2025-04-17 |
2025-04-16 |
V
Vente
|
Linetsky David
SVP, Life Sciences
Dirigeant
|
2 011
-0.9%
23,81
47 876 USD
|
2 011
-0.9%
|
23,81
|
47 876 USD
|
|
|
2025-04-17 |
2025-04-16 |
V
Vente
|
Roberts Evan
Chief Operating Officer
Dirigeant
|
1 845
-0.2%
23,81
43 924 USD
|
1 845
-0.2%
|
23,81
|
43 924 USD
|
|
|
2025-04-17 |
2025-04-16 |
V
Vente
|
Gandhi Balaji
Chief Financial Officer
Dirigeant
|
864
-0.8%
23,81
20 569 USD
|
864
-0.8%
|
23,81
|
20 569 USD
|
|
|
2025-04-17 |
2025-04-16 |
V
Vente
|
Hoffman Allison C
General Counsel & Secretary
Dirigeant
|
1 213
-0.9%
23,81
28 878 USD
|
1 213
-0.9%
|
23,81
|
28 878 USD
|
|
|
2025-04-17 |
2025-04-15 |
V
Vente
|
Hui Yvonne
Principal Accounting Officer
Dirigeant
|
314
-1.2%
24,04
7 550 USD
|
314
-1.2%
|
24,04
|
7 550 USD
|
|
|
2025-04-10 |
2025-04-09 |
VP
Vente planifiée
|
Hoffman Allison C
General Counsel & Secretary
Dirigeant
|
4 696
-3.3%
23,23
109 088 USD
|
4 696
-3.3%
|
23,23
|
109 088 USD
|
|
|
2025-04-10 |
2025-04-09 |
VP
Vente planifiée
|
Hui Yvonne
Principal Accounting Officer
Dirigeant
|
2 802
-9.8%
23,23
65 090 USD
|
2 802
-9.8%
|
23,23
|
65 090 USD
|
|
|
2025-04-10 |
2025-04-08 |
V
Vente
|
Linetsky David
SVP, Life Sciences
Dirigeant
|
96
-1.1%
24,48
2 350 USD
|
96
-1.1%
|
24,48
|
2 350 USD
|
|
|
2025-04-10 |
2025-04-08 |
V
Vente
|
Linetsky David
SVP, Life Sciences
Dirigeant
|
152
-1.6%
23,46
3 565 USD
|
152
-1.6%
|
23,46
|
3 565 USD
|
|
|
2025-04-10 |
2025-04-08 |
V
Vente
|
Linetsky David
SVP, Life Sciences
Dirigeant
|
1 534
-0.7%
24,48
37 545 USD
|
1 534
-0.7%
|
24,48
|
37 545 USD
|
|
|
2025-04-10 |
2025-04-08 |
V
Vente
|
Linetsky David
SVP, Life Sciences
Dirigeant
|
2 410
-1.1%
23,46
56 531 USD
|
2 410
-1.1%
|
23,46
|
56 531 USD
|
|
|
2025-04-10 |
2025-04-08 |
V
Vente
|
Gandhi Balaji
Chief Financial Officer
Dirigeant
|
3 129
-2.8%
24,48
76 582 USD
|
3 129
-2.8%
|
24,48
|
76 582 USD
|
|
|
2025-04-10 |
2025-04-08 |
V
Vente
|
Gandhi Balaji
Chief Financial Officer
Dirigeant
|
4 916
-4.2%
23,46
115 314 USD
|
4 916
-4.2%
|
23,46
|
115 314 USD
|
|
|
2025-04-10 |
2025-04-08 |
V
Vente
|
Hoffman Allison C
General Counsel & Secretary
Dirigeant
|
2 343
-1.6%
24,48
57 345 USD
|
2 343
-1.6%
|
24,48
|
57 345 USD
|
|
|
2025-04-10 |
2025-04-08 |
V
Vente
|
Hoffman Allison C
General Counsel & Secretary
Dirigeant
|
3 681
-2.5%
23,46
86 344 USD
|
3 681
-2.5%
|
23,46
|
86 344 USD
|
|
|
2025-04-10 |
2025-04-08 |
V
Vente
|
Roberts Evan
Chief Operating Officer
Dirigeant
|
2 813
-0.4%
24,48
68 848 USD
|
2 813
-0.4%
|
24,48
|
68 848 USD
|
|
|
2025-04-10 |
2025-04-08 |
V
Vente
|
Roberts Evan
Chief Operating Officer
Dirigeant
|
4 420
-0.6%
23,46
103 679 USD
|
4 420
-0.6%
|
23,46
|
103 679 USD
|
|
|
2025-04-10 |
2025-04-08 |
V
Vente
|
Hui Yvonne
Principal Accounting Officer
Dirigeant
|
730
-2.5%
24,48
17 867 USD
|
730
-2.5%
|
24,48
|
17 867 USD
|
|
|
2025-04-10 |
2025-04-08 |
V
Vente
|
Hui Yvonne
Principal Accounting Officer
Dirigeant
|
1 148
-3.8%
23,46
26 928 USD
|
1 148
-3.8%
|
23,46
|
26 928 USD
|
|
|
2025-04-10 |
2025-04-08 |
V
Vente
|
Indig Chaim
Chief Executive Officer
Administrateur exécutif
|
4 733
-0.4%
24,48
115 840 USD
|
4 733
-0.4%
|
24,48
|
115 840 USD
|
|
|
2025-04-10 |
2025-04-08 |
V
Vente
|
Indig Chaim
Chief Executive Officer
Administrateur exécutif
|
7 434
-0.6%
23,46
174 378 USD
|
7 434
-0.6%
|
23,46
|
174 378 USD
|
|
|
2025-04-10 |
2025-04-08 |
V
Vente
|
VanDuyn Amy Beth
SVP, Human Resources
Dirigeant
|
659
-0.5%
24,48
16 129 USD
|
659
-0.5%
|
24,48
|
16 129 USD
|
|
|
2025-04-10 |
2025-04-08 |
V
Vente
|
VanDuyn Amy Beth
SVP, Human Resources
Dirigeant
|
1 036
-0.8%
23,46
24 301 USD
|
1 036
-0.8%
|
23,46
|
24 301 USD
|
|
|
2025-03-28 |
2025-03-26 |
V
Vente
|
Gandhi Balaji
Chief Financial Officer
Dirigeant
|
1 827
-1.7%
27,46
50 177 USD
|
1 827
-1.7%
|
27,46
|
50 177 USD
|
|
|
2025-03-20 |
2025-03-19 |
V
Vente
|
Linetsky David
SVP, Life Sciences
Dirigeant
|
7
-0.1%
28,31
198 USD
|
7
-0.1%
|
28,31
|
198 USD
|
|
|
2025-03-20 |
2025-03-19 |
V
Vente
|
Linetsky David
SVP, Life Sciences
Dirigeant
|
81
-0.9%
27,85
2 256 USD
|
81
-0.9%
|
27,85
|
2 256 USD
|
|
|
2025-03-20 |
2025-03-18 |
V
Vente
|
Linetsky David
SVP, Life Sciences
Dirigeant
|
39
-0.4%
26,95
1 051 USD
|
39
-0.4%
|
26,95
|
1 051 USD
|
|
|
2025-03-19 |
2025-03-17 |
VP
Vente planifiée
|
Hoffman Allison C
General Counsel & Secretary
Dirigeant
|
3 496
-2.5%
25,32
88 519 USD
|
3 496
-2.5%
|
25,32
|
88 519 USD
|
|
|
2025-02-20 |
2025-02-19 |
VP
Vente planifiée
|
Roberts Evan
Chief Operating Officer
Dirigeant
|
177
-0.0%
30,00
5 310 USD
|
177
-0.0%
|
30,00
|
5 310 USD
|
|
|
2025-02-20 |
2025-02-19 |
VP
Vente planifiée
|
Gandhi Balaji
Chief Financial Officer
Dirigeant
|
96
-0.1%
30,00
2 880 USD
|
96
-0.1%
|
30,00
|
2 880 USD
|
|
|
2025-02-20 |
2025-02-18 |
VP
Vente planifiée
|
Roberts Evan
Chief Operating Officer
Dirigeant
|
3 519
-0.5%
30,06
105 764 USD
|
3 519
-0.5%
|
30,06
|
105 764 USD
|
|
|
2025-02-20 |
2025-02-18 |
VP
Vente planifiée
|
Gandhi Balaji
Chief Financial Officer
Dirigeant
|
5 771
-5.2%
30,04
173 377 USD
|
5 771
-5.2%
|
30,04
|
173 377 USD
|
|
|
2025-02-20 |
2025-02-18 |
VP
Vente planifiée
|
Hoffman Allison C
General Counsel & Secretary
Dirigeant
|
3 496
-2.4%
29,72
103 901 USD
|
3 496
-2.4%
|
29,72
|
103 901 USD
|
|
|
2025-02-18 |
2025-02-14 |
VP
Vente planifiée
|
Gandhi Balaji
Chief Financial Officer
Dirigeant
|
4 889
-4.2%
30,09
147 088 USD
|
4 889
-4.2%
|
30,09
|
147 088 USD
|
|
|
2025-02-18 |
2025-02-14 |
VP
Vente planifiée
|
Roberts Evan
Chief Operating Officer
Dirigeant
|
3 586
-0.5%
30,13
108 039 USD
|
3 586
-0.5%
|
30,13
|
108 039 USD
|
|
|
2025-02-18 |
2025-02-13 |
VP
Vente planifiée
|
Gandhi Balaji
Chief Financial Officer
Dirigeant
|
28 759
-19.8%
30,00
862 770 USD
|
28 759
-19.8%
|
30,00
|
862 770 USD
|
|
|
2025-02-18 |
2025-02-13 |
VP
Vente planifiée
|
Roberts Evan
Chief Operating Officer
Dirigeant
|
16 005
-2.1%
30,00
480 152 USD
|
16 005
-2.1%
|
30,00
|
480 152 USD
|
|
|
2025-02-18 |
2025-02-13 |
VP
Vente planifiée
|
Linetsky David
SVP, Life Sciences
Dirigeant
|
11 616
-5.1%
29,70
345 001 USD
|
11 616
-5.1%
|
29,70
|
345 001 USD
|
|
|
2025-02-11 |
2025-02-07 |
VP
Vente planifiée
|
Linetsky David
SVP, Life Sciences
Dirigeant
|
300
-0.1%
29,52
8 857 USD
|
300
-0.1%
|
29,52
|
8 857 USD
|
|
|
2025-02-07 |
2025-02-05 |
VP
Vente planifiée
|
Linetsky David
SVP, Life Sciences
Dirigeant
|
720
-0.3%
29,50
21 241 USD
|
720
-0.3%
|
29,50
|
21 241 USD
|
|
|
2025-01-31 |
2025-01-29 |
VP
Vente planifiée
|
Linetsky David
SVP, Life Sciences
Dirigeant
|
500
-0.2%
29,68
14 841 USD
|
500
-0.2%
|
29,68
|
14 841 USD
|
|
|
2025-01-29 |
2025-01-28 |
VP
Vente planifiée
|
Hoffman Allison C
General Counsel & Secretary
Dirigeant
|
6 235
-4.1%
28,50
177 698 USD
|
6 235
-4.1%
|
28,50
|
177 698 USD
|
|
|
2025-01-29 |
2025-01-27 |
V
Vente
|
Hoffman Allison C
General Counsel & Secretary
Dirigeant
|
1 979
-1.3%
28,15
55 710 USD
|
1 979
-1.3%
|
28,15
|
55 710 USD
|
|
|
2025-01-29 |
2025-01-27 |
V
Vente
|
Hoffman Allison C
General Counsel & Secretary
Dirigeant
|
4 577
-2.9%
27,18
124 425 USD
|
4 577
-2.9%
|
27,18
|
124 425 USD
|
|
|
2025-01-29 |
2025-01-27 |
V
Vente
|
Gandhi Balaji
Chief Financial Officer
Dirigeant
|
1 453
-1.0%
28,15
40 903 USD
|
1 453
-1.0%
|
28,15
|
40 903 USD
|
|
|
2025-01-29 |
2025-01-27 |
V
Vente
|
Gandhi Balaji
Chief Financial Officer
Dirigeant
|
3 360
-2.2%
27,18
91 341 USD
|
3 360
-2.2%
|
27,18
|
91 341 USD
|
|
|
2025-01-29 |
2025-01-27 |
V
Vente
|
Indig Chaim
Chief Executive Officer
Administrateur exécutif
|
7 923
-0.6%
28,15
223 036 USD
|
7 923
-0.6%
|
28,15
|
223 036 USD
|
|
|
2025-01-29 |
2025-01-27 |
V
Vente
|
Indig Chaim
Chief Executive Officer
Administrateur exécutif
|
18 325
-1.4%
27,18
498 161 USD
|
18 325
-1.4%
|
27,18
|
498 161 USD
|
|
|
2025-01-29 |
2025-01-27 |
V
Vente
|
Roberts Evan
Chief Operating Officer
Dirigeant
|
3 235
-0.4%
28,15
91 067 USD
|
3 235
-0.4%
|
28,15
|
91 067 USD
|
|
|
2025-01-29 |
2025-01-27 |
V
Vente
|
Roberts Evan
Chief Operating Officer
Dirigeant
|
7 481
-1.0%
27,18
203 369 USD
|
7 481
-1.0%
|
27,18
|
203 369 USD
|
|
|
2025-01-29 |
2025-01-27 |
V
Vente
|
Linetsky David
SVP, Life Sciences
Dirigeant
|
3 527
-1.5%
28,15
99 287 USD
|
3 527
-1.5%
|
28,15
|
99 287 USD
|
|
|
2025-01-29 |
2025-01-27 |
V
Vente
|
Linetsky David
SVP, Life Sciences
Dirigeant
|
8 158
-3.4%
27,18
221 774 USD
|
8 158
-3.4%
|
27,18
|
221 774 USD
|
|
|
2025-01-29 |
2025-01-27 |
V
Vente
|
VanDuyn Amy Beth
SVP, Human Resources
Dirigeant
|
1 049
-0.9%
28,15
29 530 USD
|
1 049
-0.9%
|
28,15
|
29 530 USD
|
|
|
2025-01-29 |
2025-01-27 |
V
Vente
|
VanDuyn Amy Beth
SVP, Human Resources
Dirigeant
|
2 426
-2.1%
27,18
65 950 USD
|
2 426
-2.1%
|
27,18
|
65 950 USD
|
|
|
2025-01-27 |
2025-01-24 |
VP
Vente planifiée
|
Hui Yvonne
Principal Accounting Officer
Dirigeant
|
127
-0.5%
28,00
3 556 USD
|
127
-0.5%
|
28,00
|
3 556 USD
|
|
|
2025-01-22 |
2025-01-21 |
V
Vente
|
Gandhi Balaji
Chief Financial Officer
Dirigeant
|
5 827
-3.9%
27,31
159 139 USD
|
5 827
-3.9%
|
27,31
|
159 139 USD
|
|
|
2025-01-22 |
2025-01-21 |
V
Vente
|
Hoffman Allison C
General Counsel & Secretary
Dirigeant
|
8 426
-5.5%
27,31
230 120 USD
|
8 426
-5.5%
|
27,31
|
230 120 USD
|
|
|
2025-01-22 |
2025-01-21 |
V
Vente
|
Roberts Evan
Chief Operating Officer
Dirigeant
|
12 749
-1.7%
27,31
348 184 USD
|
12 749
-1.7%
|
27,31
|
348 184 USD
|
|
|
2025-01-22 |
2025-01-21 |
V
Vente
|
VanDuyn Amy Beth
SVP, Human Resources
Dirigeant
|
4 720
-4.1%
27,31
128 907 USD
|
4 720
-4.1%
|
27,31
|
128 907 USD
|
|
|
2025-01-22 |
2025-01-21 |
V
Vente
|
Indig Chaim
Chief Executive Officer
Administrateur exécutif
|
21 692
-1.7%
27,31
592 424 USD
|
21 692
-1.7%
|
27,31
|
592 424 USD
|
|
|
2025-01-22 |
2025-01-21 |
V
Vente
|
Linetsky David
SVP, Life Sciences
Dirigeant
|
13 873
-5.8%
27,31
378 881 USD
|
13 873
-5.8%
|
27,31
|
378 881 USD
|
|
|
2025-01-17 |
2025-01-15 |
V
Vente
|
Hoffman Allison C
General Counsel & Secretary
Dirigeant
|
1 089
-0.7%
26,98
29 383 USD
|
1 089
-0.7%
|
26,98
|
29 383 USD
|
|
|
2025-01-17 |
2025-01-15 |
VP
Vente planifiée
|
Hoffman Allison C
General Counsel & Secretary
Dirigeant
|
3 496
-2.2%
26,87
93 938 USD
|
3 496
-2.2%
|
26,87
|
93 938 USD
|
|
|
2025-01-17 |
2025-01-15 |
V
Vente
|
Gandhi Balaji
Chief Financial Officer
Dirigeant
|
836
-0.6%
26,98
22 556 USD
|
836
-0.6%
|
26,98
|
22 556 USD
|
|
|
2025-01-17 |
2025-01-15 |
V
Vente
|
Roberts Evan
Chief Operating Officer
Dirigeant
|
1 785
-0.2%
26,98
48 162 USD
|
1 785
-0.2%
|
26,98
|
48 162 USD
|
|
|
2025-01-17 |
2025-01-15 |
V
Vente
|
VanDuyn Amy Beth
SVP, Human Resources
Dirigeant
|
604
-0.5%
26,98
16 297 USD
|
604
-0.5%
|
26,98
|
16 297 USD
|
|
|
2025-01-17 |
2025-01-15 |
V
Vente
|
Linetsky David
SVP, Life Sciences
Dirigeant
|
1 946
-0.8%
26,98
52 506 USD
|
1 946
-0.8%
|
26,98
|
52 506 USD
|
|
|
2025-01-17 |
2025-01-15 |
V
Vente
|
Indig Chaim
Chief Executive Officer
Administrateur exécutif
|
2 990
-0.2%
26,98
80 674 USD
|
2 990
-0.2%
|
26,98
|
80 674 USD
|
|
